AKUMS — Akums Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹79.62bn
- IN₹64.27bn
- IN₹43.59bn
Annual cashflow statement for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,932 | 1,503 | -453 | 3,453 | 3,821 |
| Depreciation | |||||
| Non-Cash Items | 5,367 | 449 | 4,305 | 143 | 97.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4,064 | -1,314 | -129 | -478 | 6,348 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 319 | 1,766 | 4,979 | 4,652 | 11,812 |
| Capital Expenditures | -2,576 | -3,288 | -3,114 | -2,723 | -2,305 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 228 | 241 | -190 | -2,755 | -6,997 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,348 | -3,047 | -3,304 | -5,478 | -9,303 |
| Financing Cash Flow Items | -89.1 | -404 | -434 | -345 | -160 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,360 | 1,245 | -1,080 | 728 | 339 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 331 | -35.3 | 594 | -98.6 | 2,848 |